Sign Up Today and Learn More About Lion TCR Stock
Invest in or calculate the value of your shares in Lion TCR or other pre-IPO companies through EquityZen's platform.
Lion TCR Stock (LITC)
Lion TCR is a clinical-stage biotechnology company.
About Lion TCR Stock
Founded
2015
Industries
Software, Artificial Intelligence, Data and Analytics
Lion TCR Press Mentions
Stay in the know about the latest news on Lion TCR
Lion TCR's Liocyx-M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV-Related Hepatocellular Carcinoma
en • Feb 12, 2025
Lion TCR's Liocyx-M004 Receives FDA Clearance to Launch Global Multicenter Phase 2 Clinical Trial in HBV-Related Hepatocellular Carcinoma
morningstar • Feb 12, 2025
Hbv antigen-specific binding molecules and fragments thereof
patents • Feb 12, 2025
SG biotech firm Lion TCR's losses up 27% in 2023, no revenue yet
dealstreetasia • Aug 09, 2024
Are these T cell receptor (TCR) therapy companies on your radar?
labiotech • May 23, 2024
Lion TCR Management
Leadership team at Lion TCR
COO
Stephen Lim
Co-Founder, Chairman & CEO
Lietao Li
Join now and verify your accreditation status to gain access to:
- Lion TCR Current Valuation
- Lion TCR Stock Price
- Lion TCR Management
- Available deals in Lion TCR and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Lion TCR Cap Table and Funding History by Share Class and Liquidity Preferences
- Lion TCR Revenue and Financials
- Lion TCR Highlights
- Lion TCR Business Model
- Lion TCR Risk Factors
- Lion TCR Research Report from SACRA Research
Trading Lion TCR Stock
How to invest in Lion TCR stock?
Accredited investors can buy pre-IPO stock in companies like Lion TCR through EquityZen funds. These investments are made available by existing Lion TCR shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Lion TCR stock?
Shareholders can sell their Lion TCR stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
